Abstract
Alzheimer's disease is the most common form of dementia. Although the majority of the cases occur sporadically, in some rare cases Alzheimer's disease is genetically inherited. Pathologically, Alzheimer's disease is characterized by the accumulation of senile plaques within the extracellular space of brain regions known to be important for intellectual functions. In addition to senile plaques, deposits of identical biochemical composition are found in the walls of meningeal and cerebral blood vessels. Senile plaques are surrounded by degenerating neurons indicating a toxic interference of amyloid plaques with neurons. The major component of senile plaques is the 4 kDa amyloid β-peptide. This peptide has been shown to exhibit neurotoxic properties when added to cultured neurons, or injected into rat brains. Amyloid β-peptide is derived from a high molecular weight precursor, the β-amyloid precursor protein, by proteolytic processing. Mutations responsible for the early onset of Alzheimer's disease in some families are found within the gene coding for the β-amyloid precursor protein. These mutations strongly influence the generation of amyloid β-peptide resulting in a significant overproduction of the peptide or the generation of elongated forms which are known to aggregate and precipitate much faster. Moreover, mutations found in other genes known to cause early onset of Alzheimer's disease have been shown to interfere directly with the production or precipitation of amyloid β-peptide.
Similar content being viewed by others
References
Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90:2092–2096
Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) β-amyloid fibrils induce tau phosphorylation and loss of microtubule bindings. Neuron 14:879–888
Cai X, Golde T, Younkin S (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514–516
Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353:844–846
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672–674
Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J, Winblad B, Venizelos N, Lannfelt L, Selkoe DJ (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91:11993–11997
Citron M, Teplow DB, Selkoe DJ (1995) Generation of amyloid β protein from its precursor is sequence specific. Neuron 14:661–670
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JP, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7:180–183
Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Müller-Hill B, Basters CL, Beyreuther K (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7:949–957
Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward P (1990) Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248:1122–1124
Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, Janes L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704–706
George-Hyslop P St., Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin J-F, Montesi M, Bruni A, Sorbi S, Rainero I, Pinessi L, Pollen D, Polinsky R, Nee L, Kennedy J, Macciardi F, Rogaeva E, Liang Y, Alexandrova N, Lukiw W, Schlumpf K, Tanzi R, Tsuda T, Farrer L, Cantu JM, Duara R, Amaducci L, Bergamini L, Gusella J, Roses A, Crapper McLachlan D (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet 2:330–334
Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular and amyloid protein. Biochem Biophys Res Commun 120:885–890
Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein T (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4813–4917
Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268:3021–3024
Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-amyloid protein precursor. J Biol Chem 269:17741–17748
Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ (1992a) Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357:500–503
Haass C, Selkoe DJ (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75:1039–1042
Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski B, Lieberburg I, Koo E, Schenk D, Teplow D, Selkoe DJ (1992b) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325
Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Medicine 1:1291–1296
Hendriks L, Duijn CM van, Cras P, Cruts M, Van Hul W, Harskamp F van, Warren A, McInnis MG, Antonarakis SE, Martin JJ, Hofman A, Van Broeckhoven C (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at cordon 692 of the β-amyloid precursor gene. Nature Genet 1:218–221
Jarrett J, Lansbury P (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and Scrapie? Cell 73:1055–1058
Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4-protein resembles a cell-surface receptor. Nature 325:733–736
Koo EH, Squazzo S (1994) Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 269:17386–17389
Kowall NW, Flint Beal M, Busciglio J, Duffy LR, Yankner BA (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance. P Proc Natl Acad Sci USA 88:7247–7251
LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 269:23403–23406
LaDu MJ, Pederson TM, Frai DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attenuates isoformspecific binding to β-amyloid. J Biol Chem 270:9039–9042
Lorenzo A, Yankner BA (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243–12247
Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756–760
Ma J, Yee A, Bryan-Brewer H Jr, Potter H (1994) Amyloid associated proteins αI-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92–94
Mullan M, Crawford F (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 16:398–403
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1:345–347
Murrel J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97–99
Oltersdorf T, Ward P, Henriksson T, Beattie E, Neve R, Lieberburg I, Fitz I (1990) The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem 265:4492–4497
Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:1–6
Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on apo E genotype and duration of disease. J Neuropathol Ex Neurol 53:429–437
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94:860–869
Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonos ME, Potter H, Heston LL, Martin GM (1992) Genetic linkage evidence for a familial Alzheimer disease locus on chromosome 14. Science 258:1–4
Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487–498
Selkoe DJ (1994a) Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol 4:708–716
Selkoe DJ (1994b) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10:373–403
Selkoe DJ (1994c) Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489–517
Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Schwindelhurst C, McCormack R, Wolfert R, Selkoe DJ, Lieberburg I, Schenk D (1992) Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325–327
Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis D, Bryant K, Fritz C, Galasko D, Thal L, Lieberburg I, Schenk D (1993) Secretion of β-amyloid precursor protein cleaved at the amino-terminus of β-amyloid peptide. Nature 361:260–262
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop P (1995) Cloning of a gene bearing missense mutations in early-onset Alzheimer's disease. Nature 375:754–760
Shoji M, Golde TE, Ghiso J, Cheung T, Estus S, Shaffer L, Cai X, McKay D, Tinter R, Frangione B, Younkin S (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126–129
Strittmatter WJ, Roses AD (1995) Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 92:4725–4727
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977–1981
Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jake R, Alberts MJ, Gilbert JD, Han SH, Hulette C, Einstein G, Schmecjel DE, Pericak-Vance MA, Roses AD (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 125:163–171
Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckamn C, Golde TER, Younkin SG (1994) An increased percentage of long amyloid β-protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264:1336–1340
Ueda K, Masliah E, Saitoh T, Bakalis SL, Scoble H, Kosik KS (1990) Alz-50 recognizes a phosphorylated epitope of tau protein. Neuroscience 10:3295–3304
Weidemann A, König G, Bunke D, Fischer P, Masters CL, Beyreuther K (1989) Identification, biogenesis and localization of precursors of Alzheimer's diseae A4 amyloid protein. Cell 57:115–126
Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B (1993) Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 192:359–365
Yamazaki T, Selkoe DJ, Koo EH (1995) Trafficking of cell-surface β-amyloid precursor protein: retrogate and transcytotic transport in cultured neurons. J Cell Biol 129:431–442
Yankner B, Duffy L, Kirschner D (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279–282
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haass, C. The molecular significance of amyloid β-peptide for Alzheimer's disease. Eur Arch Psychiatry Clin Nuerosci 246, 118–123 (1996). https://doi.org/10.1007/BF02189111
Issue Date:
DOI: https://doi.org/10.1007/BF02189111